Shop - Prostate Specific Antigen (Total)

Prostate-Specific Antigen (Total)

1. Definition: Total Prostate-Specific Antigen (PSA) is a protein produced exclusively by prostate cells. The total PSA test measures the overall amount of PSA in the blood, which can help assess prostate health and detect potential prostate disorders, including prostate cancer.
2. Testing Methodology: The Total PSA test requires a blood sample drawn from a vein. The sample is sent to a laboratory for analysis, where the total PSA concentration is measured, typically reported in nanograms per milliliter (ng/mL).
3. Clinical Significance: Elevated total PSA levels can indicate various prostate conditions, including prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis. The test is an important tool in the early detection and monitoring of prostate cancer, particularly in men over 50 or those with risk factors.
4. Risk Assessment: Total PSA testing is commonly used in conjunction with other diagnostic tools to evaluate prostate health. Elevated levels may prompt further investigations, such as a digital rectal exam (DRE) or prostate biopsy, to confirm or rule out cancer.
5. Guidelines for Interpretation: Normal total PSA levels typically range from 0 to 4.0 ng/mL, although this range may vary slightly by laboratory and age. Levels above this range may indicate the need for further evaluation, with higher levels correlating with an increased likelihood of prostate cancer.
6. Follow-Up and Management: If total PSA levels are elevated, healthcare providers may recommend additional testing or monitoring strategies, including repeat PSA testing or imaging studies. Management decisions are made based on total PSA results, clinical findings, and individual patient factors, ensuring personalized care in prostate health management.